Clinical Roundup SWOG study: Cancer trial participation does not eliminate disparities for poor patients March 19, 2021Vol.47 No.11
Clinical Roundup Trial of tilsotolimod + ipilimumab in anti-PD-1 refractory advanced melanoma fails to meet ORR March 19, 2021Vol.47 No.11
Clinical Roundup Aveo, BMS collaborate on phase III trial of Fotivda + Opdivo in IO relapsed RCC March 19, 2021Vol.47 No.11
Clinical Roundup Hopkins study: Cancer immunotherapy approach targets common genetic alteration March 19, 2021Vol.47 No.11
Clinical Roundup UAB’s Cancer Center, GO2 Foundation for Lung Cancer initiate STRIDES study to increase African American participation in lung cancer trials March 19, 2021Vol.47 No.11
Clinical Roundup New targeted agent achieves nearly 30% response rate in trial with patients with uterine serous carcinoma March 19, 2021Vol.47 No.11
Drugs & Targets CYNK-001 receives Fast Track designation from FDA for recurrent glioblastoma multiforme March 19, 2021Vol.47 No.11
Drugs & Targets Geneseeq, Illumina to develop and commercialize comprehensive cancer in-vitro diagnostic NGS kit in China March 19, 2021Vol.47 No.11
Drugs & Targets CD&R, Merck GHI, and McKesson Ventures invest oncology data and informatics company M2Gen March 19, 2021Vol.47 No.11
